Inactive Instrument

Highlights Isofol Medical AB (publ) Nasdaq Stockholm

Equities

SE0009581051

Highlights

Unlock all the news: Be the first to know and act before the market!

Isofol Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/02	CI
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02	CI
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	29/12	CI
Isofol Receives the First Results from Laboratory Tests of Arfolitixorin	08/12	CI
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Isofol Medical AB Announces Results from the Modelle 001 Study	05/23/05	CI
Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Isofol Medical AB Presents Conclusions from the In-Depth Analysis of the AGENT Study	04/23/04	CI
Isofol Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	03/23/03	CI
Isofol Medical AB Initiates Preclinical Evaluation of arfolitixorin with Oncosyne AS	28/23/28	CI
Isofol Medical AB Initiates A Stepwise Process for the Continued Development of Its Drug Candidate Arfolitixorin	06/23/06	CI
Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	22/23/22	CI
Isofol Medical AB Proposes No Dividend for the Financial Year 2022	22/23/22	CI
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Isofol Medical AB Approves Not to Pay Extra Dividend	13/23/13	CI
Isofol Medical AB Proposes Dividend, Payable on 20 February 2023	19/23/19	CI
Isofol Medical AB Announces Final Data from the Agent Study Confirms Topline Results	25/22/25	CI
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Isofol Medical Reports Data from the Agent Study	07/22/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Isofol Medical AB (publ) Nasdaq Stockholm

Equities

SE0009581051

Highlights

Filters